A Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
Clinical trial NCT02611505 · COMPLETED
Trial details
- NCT number
- NCT02611505
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2017-02-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.